Inner Mongolia Furui Medical Science Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Inner Mongolia Furui Medical Science Co., Ltd. carries a market capitalization of 11.60B, placing it among publicly traded companies globally. Its enterprise value stands at 8.22B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 11.60B |
| Enterprise Value | 8.22B |
Share Statistics
Inner Mongolia Furui Medical Science Co., Ltd. currently has 266.36M shares outstanding.
| Shares Outstanding | 266.36M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Inner Mongolia Furui Medical Science Co., Ltd. trades at a trailing price-to-earnings ratio of 93.96. The price-to-sales ratio is 5.95, and the price-to-book ratio stands at 7.77.
| PE Ratio | 93.96 |
| PS Ratio | 5.95 |
| PB Ratio | 7.77 |
| P/TBV Ratio | 5.81 |
| P/FCF Ratio | 35.00 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Inner Mongolia Furui Medical Science Co., Ltd. trades at an EV/EBITDA multiple of 26.66 and an EV/FCF ratio of 33.81. The EV/Sales ratio of 5.79 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 26.66 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.79 |
| EV / EBITDA | 26.66 |
| EV / EBIT | 26.66 |
| EV / FCF | 33.81 |
Financial Position
Inner Mongolia Furui Medical Science Co., Ltd. maintains a current ratio of 4.20, meaning it holds 4.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.49, indicating elevated leverage, while an interest coverage ratio of 103.36 demonstrates strong ability to service its debt obligations.
| Current Ratio | 4.20 |
| Quick Ratio | 1.92 |
| Debt / Equity | 3.49 |
| Debt / EBITDA | 0.25 |
| Interest Coverage | 103.36 |
Financial Efficiency
Inner Mongolia Furui Medical Science Co., Ltd. posts a return on equity of 8.61 and a return on invested capital of 9.71.
| Return on Equity (ROE) | 8.61 |
| Return on Assets (ROA) | 3.04 |
| Return on Invested Capital (ROIC) | 9.71 |
| Return on Capital Employed (ROCE) | 1.32 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.70 |
Taxes
Over the trailing twelve months, Inner Mongolia Furui Medical Science Co., Ltd. has paid 75.85M in income taxes, reflecting an effective tax rate of 31.88.
| Income Tax | 75.85M |
| Effective Tax Rate | 31.88 |
Stock Price Statistics
Inner Mongolia Furui Medical Science Co., Ltd.'s stock has gained approximately 36.81096% over the past 52 weeks. The 50-day moving average sits at 47.67, while the 200-day moving average is 62.34.
| Beta (5Y) | N/A |
| 52-Week Price Change | 36.81096% |
| 50-Day Moving Average | 47.67 |
| 200-Day Moving Average | 62.34 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Inner Mongolia Furui Medical Science Co., Ltd. generated 1.42B in revenue and converted that into 89.86M in net income, yielding earnings per share of 0.62. EBITDA reached 308.48M, while operating income came in at 308.48M.
| Revenue | 1.42B |
| Gross Profit | 1.05B |
| Operating Income | 308.48M |
| Pretax Income | 237.93M |
| Net Income | 89.86M |
| EBITDA | 308.48M |
| EBIT | 308.48M |
| Earnings Per Share (EPS) | 0.62 |
Balance Sheet
Inner Mongolia Furui Medical Science Co., Ltd. holds 715.74M in cash and equivalents against 78.27M in total debt, resulting in a net debt position of -595.24M. Total book value stands at 1.09B, with working capital of 1.19B providing operational flexibility.
| Cash & Cash Equivalents | 715.74M |
| Total Debt | 78.27M |
| Net Debt | -595.24M |
| Equity (Book Value) | 1.09B |
| Book Value Per Share | 4.18 |
| Working Capital | 1.19B |
Cash Flow
After subtracting -241.21M in capital expenditures, free cash flow totaled -241.21M - equivalent to -0.93 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -241.21M |
| Free Cash Flow | -241.21M |
| FCF Per Share | -0.93 |
Margins
Inner Mongolia Furui Medical Science Co., Ltd. operates with a gross margin of 73.72, reflecting its pricing power and cost economics. The operating margin of 21.73 and net profit margin of 6.33 provide insight into operational efficiency.
| Gross Margin | 73.72 |
| Operating Margin | 21.73 |
| Pretax Margin | 16.76 |
| Profit Margin | 6.33 |
| EBITDA Margin | 21.73 |
Dividends & Yields
The company's payout ratio of 0.89 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.01 |
| Dividend Yield | N/A |
| Payout Ratio | 0.89 |
| Shareholder Yield | -1.37 |
| FCF Yield | 2.86 |
Stock Splits
Inner Mongolia Furui Medical Science Co., Ltd.'s most recent stock split took place on July 6, 2015 with a 1:2 split ratio.
| Last Split Date | 7/6/2015 |
| Split Ratio | 1:2 |
Scores
Inner Mongolia Furui Medical Science Co., Ltd. posts an Altman Z-Score of 7.65, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.65 |